Previous Page  285 / 300 Next Page
Information
Show Menu
Previous Page 285 / 300 Next Page
Page Background

Notes forming part of onancial statements (Contd.)

Annual Report 2016-17

285

ESOP

Scheme

Particulars

Year Ended

Outstanding at

the beginning of

the Year

Granted

during the

Year

Forfeited

during the

Year

Exercised

during the

Year

Outstanding

at the end of

the Year

Exercisable at

the end of the

Year

Scheme XI

Number of Option March 31, 2017

402,600

-

-

-

402,600

-

Weighted Average

Price

March 31, 2017

10.00

-

-

-

10.00

-

Number of Option March 31, 2016

476,000

16,000

89,400

-

402,600

-

Weighted Average

Price

March 31, 2016

10.00

10.00

1000

-

10.00

-

Scheme XII

Number of Option March 31, 2017

-

67,300

-

-

67,300

-

Weighted Average

Price

March 31, 2017

-

10.00

-

-

10.00

-

Number of Option March 31, 2016

-

-

-

-

-

-

Weighted Average

Price

March 31, 2016

-

-

-

-

-

-

Total

Number of Option March 31, 2017

3,642,422

67,300

157,600

679,508

2,872,614

2,402,714

Number of Option March 31, 2016

4,587,518

16,000

89,400

871,696

3,642,422

2,843,106

The weighted average share price for the period over which stock options were exercised was

`

648.60 (previous year

`

676.75).

c) Details of exercise price for stock options outstanding at the end of the year

Scheme

Range of

exercise price

As at March 31, 2017

As at March 31, 2016

No. of Options

outstanding

Weighted average

remaining

contractual life

(in years)

No. of Options

outstanding

Weighted average

remaining

contractual life

(in years)

Scheme I

2.04 – 9.57

6,583

Note (i)

8,510

Note (i)

Scheme II

12.96 – 48.21

4,603

4.46

7,603

5.46

Scheme III

12.96 – 48.21

238,827

Note (i)

268,394

Note (i)

Scheme IV

22.23 – 61.12

827,944

5.84

970,329

6.76

Scheme V

22.23 – 44.14

116,446

Note (i)

132,534

Note (i)

Scheme VI

22.23 – 30.67

-

-

-

-

Scheme VII

24.17 – 61.12

55,887

5.57

101,469

7.54

Scheme VIII

48.21 – 48.21

-

-

-

-

Scheme IX

54.74 – 54.74

163,777

6.03

174,963

7.04

Scheme X

157.58 – 279.70

988,647

1.51

1,576,020

2.61

Scheme XI

10.00

402,600

1.25

402,600

2.25

Scheme XII

10.00

67,300

0.25

-

-

Note (i) No contractual life is deoned in the scheme

d) Effect of the employee share-based payment plans on the statement of proot and loss and on its onancial

position

Compensation expense arising from equity-settled employee share based payment plans for the year ended

March 31, 2017 amounted to

`

46.79 million (Previous year

`

33.89 million). The liability for employee stock options

outstanding as at March 31, 2017 is

`

187.12 million (Previous year

`

147.09 million).